Back to search

National and Kapodistrian University of Athens

Molecular basis of inhibition and resistance of the influenza M2 ion channel by aminoadamantane drugs and discovery of nomel resistance - breaking inhibitors targeting the mutant M2 proton channel

Abstract

dc:description

Amantadine (Amt (1)) and rimantadine (Rim (2)) are blockers of proton transport by influenza A virus Μ2 ion channel protein, and approved as prophylactics and therapeutics against influenza A wild type (WT) viruses. However, since 2005, the amantadine-insensitive Ser-to-Asn mutation at position 31 (S31N) in M2 protein has become globally prevalent, abrogating the clinical usefulness of amantadine3,4and possibly other previously reported M2 inhibitors. Thus, new agents are needed to combat drug-resistant strains of influenza.The primary binding site of amantadine and rimantadine is the transmembrane domain lumen (TM, amino acids 22-46) in the four-helix bundle of tetrameric M2 WT, that forms the proton transport path. According to high resolution structures from X-ray and solid state NMR (ssNMR) experiments published between 2008-2011 by Tim Cross, William DeGrado, and Mei Hong in the highest impact factor Journals i.e., Nature, JACS etc, the M2TM protein channel is blocked by amantadine and rimantadine via a pore-binding mechanism. The adamantyl cage in these molecules is tightly contacted on all sides by V27 and A30 side chains, producing a steric occlusion of proton transport and thereby preventing the continuation of the viral life cycle. The ssNMR results also demonstrated that the ammonium group of these drugs is pointing towards the four H37 residues at the C-end. 9 This orientation can be stabilized only through hydrogen bonds between the ligand and (a) with water molecules in the channel lumen between the imidazoles of H37 and the ligand and (b) possibly with A30 carbonyls in the vicinity, according to experimental and molecular dynamics (MD) simulations data. Provided that M2TM is a minimal model for M2 binding, these experimental high resolution structures can be used for the prediction of new ligands binding more effectively to the M2TM pore for example through MD simulations19 or more precisely by binding free energy calculations.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tzitzoglaki, Christina
  • Τζιτζογλάκη, Χριστίνα

Subjects

dc:subject × 7

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45302

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tzitzoglaki, Christina; Τζιτζογλάκη, Χριστίνα. Molecular basis of inhibition and resistance of the influenza M2 ion channel by aminoadamantane drugs and discovery of nomel resistance - breaking inhibitors targeting the mutant M2 proton channel. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/45302